ReviewMolecular neurobiology2026
Failure of Neuroinflammatory Resolution in Brain Aging: Molecular Mechanisms and an Integrative Framework of Microglial Inflammometabolic Locking.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistent neuroinflammation is a central feature of brain aging and a common pathological context across neurodegenerative diseases. Although microglial activation has been extensively studied, why inflammatory responses in aging brains become increasingly difficult to resolve remains insufficiently understood. In this review, we propose inflammometabolic locking as an evidence-informed working framework describing impaired recovery and declining reversibility of microglial states. Rather than viewing persistent neuroinflammation simply as prolonged activation, the framework emphasizes failure of inflammatory exit and homeostatic re-entry. We integrate current evidence across four interrelated domains: metabolic remodeling, defective lipid handling and post-phagocytic processing, disrupted organelle homeostasis, and persistent transcriptional and epigenetic remodeling. Abnormalities across these domains may become functionally coupled and mutually reinforcing, progressively limiting microglial plasticity and recovery. Their pathological significance therefore depends not only on their presence, but also on whether they resolve as pathological burden declines and whether clearance, repair, and homeostatic functions recover. By distinguishing transient adaptation from locking-like states, this recovery-oriented framework suggests that therapeutic strategies should aim not only to suppress inflammatory output but also to restore microglial recovery capacity. Inflammometabolic locking remains a working hypothesis requiring longitudinal and intervention-based validation.
Indexed as
Identifiers
42905318What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.